0001062993-23-018392.txt : 20230921 0001062993-23-018392.hdr.sgml : 20230921 20230921203212 ACCESSION NUMBER: 0001062993-23-018392 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230815 FILED AS OF DATE: 20230921 DATE AS OF CHANGE: 20230921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRETHLEIN ANDREW J CENTRAL INDEX KEY: 0001270921 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20859 FILM NUMBER: 231270059 MAIL ADDRESS: STREET 1: 651 GATEWAY BLVD STE 950 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GERON CORP CENTRAL INDEX KEY: 0000886744 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 752287752 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 919 EAST HILLSDALE BOULEVARD STREET 2: SUITE 250 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6504737700 MAIL ADDRESS: STREET 1: 919 EAST HILLSDALE BOULEVARD STREET 2: SUITE 250 CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: GERON CORPORATION DATE OF NAME CHANGE: 19960521 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-08-15 0000886744 GERON CORP GERN 0001270921 GRETHLEIN ANDREW J C/O GERON CORPORATION 919 E. HILLSDALE BLVD, SUITE 250 FOSTER CITY CA 94404 0 1 0 0 EVP, Chief Operating Officer 0 Employee Stock Option (right to buy) 1.72 2023-08-15 4 A 0 221544 0 A 2023-08-15 2028-11-06 Common Stock 221544 221544 D Performance-based stock option granted on November 7, 2018 and vested in full on August 15, 2023 upon acceptance of the NDA by the US FDA for imetelstat in lower risk MDS. /s/ Olivia Bloom for Andrew J. Grethlein 2023-09-21